Related Experiment Video
Updated: Jul 4, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
B-type natriuretic peptide for diagnosis and therapy
1Department of Medicine, Laboratory of Cardiovascular Biochemistry, Centre de Recherche, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montréal, QC, Canada. marek.jankowski@umontreal.ca
Recent Patents on Cardiovascular Drug Discovery
|June 10, 2008
Summary
Brain natriuretic peptide (BNP) is a key marker for diagnosing heart failure (HF) and assessing left ventricular dysfunction. While promising for prognosis, its use in treatment guidance requires further validation.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Brain natriuretic peptide (BNP) is crucial for cardiovascular homeostasis.
- Elevated plasma BNP indicates left ventricular dysfunction and correlates with heart failure (HF) severity.
Purpose of the Study:
- To evaluate BNP as a clinical marker for diagnosing HF in patients with unexplained dyspnea.
- To explore other potential applications of BNP, including screening, prognosis, and treatment titration.
Main Methods:
- Utilized laboratory-based and point-of-care fully-automated immunoassays for BNP and N-terminal proBNP analysis.
- Reviewed patented inventions and reagents for diagnosing heart pathologies.
- Examined the use of recombinant BNP in managing acute decompensated HF.
Main Results:
- BNP is a valuable diagnostic marker for HF in patients with dyspnea.
- BNP and N-terminal proBNP are measurable via automated immunoassays.
- Recombinant BNP for acute decompensated HF showed safety concerns and no proven survival benefit over existing treatments.
Conclusions:
- BNP is an important diagnostic tool for heart failure.
- Further validation is needed for BNP's prognostic and therapeutic guidance roles.
- Current evidence does not support recombinant BNP over standard treatments for acute decompensated HF.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...